Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation
Teshima, Yasutomo, Kizaki, Minako, Kurihara, Ryohei, Kano, Ryosuke, Harumiya, MikiJournal:
International Journal of Clinical Oncology
DOI:
10.1007/s10147-020-01737-3
Date:
July, 2020
File:
PDF, 637 KB
2020